Alnylam Pharmaceuticals (ALNY) Receivables - Net (2009 - 2026)
Alnylam Pharmaceuticals (ALNY) reported Receivables - Net of $912.74 million for Q2 2026, up 60.9% from $567.11 million a year earlier and up 3.3% from the prior quarter.
Powered by 
Analysis
Alnylam Pharmaceuticals (ALNY) Receivables - Net (2009 - 2026) Analysis & Trends
At the end of FY2025, Alnylam Pharmaceuticals posted Receivables - Net of $777.57 million, up 91.8% from FY2024.
- Receivables - Net has increased for seven consecutive years, with a five-year compound annual growth rate of 50.0% (FY2020 to FY2025).
- By year, Receivables - Net came in at $405.31 million in FY2024 (+23.6%), $327.79 million in FY2023 (+37.7%), $237.96 million in FY2022 (+19.8%) and $198.57 million in FY2021 (+93.9%).
- Five-year quarterly Receivables - Net spans a low of $141.06 million in Q3 2021 and a high of $964.77 million in Q3 2025.
- Year over year, Receivables - Net has now increased in each of the last 16 quarters, with growth averaging 72.8% over the last eight quarters.
- The high point for year-over-year Receivables - Net in five years was Q3 2025 (growth of 172.6%); the low point was Q2 2022 (a decline of 2.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $883.96 million (Q1 2026), $777.57 million (Q4 2025) and $964.77 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn |
| 10 | Alnylam Pharmaceuticals | 34.23 Bn | 22.28 Bn | 992.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 912.74 Mn |
| Mar 31, 2026 | 883.96 Mn |
| Dec 31, 2025 | 777.57 Mn |
| Sep 30, 2025 | 964.77 Mn |
| Jun 30, 2025 | 567.11 Mn |
| Mar 31, 2025 | 418.04 Mn |
| Dec 31, 2024 | 405.31 Mn |
| Sep 30, 2024 | 353.85 Mn |
| Jun 30, 2024 | 309.48 Mn |
| Mar 31, 2024 | 321.38 Mn |
| Dec 31, 2023 | 327.79 Mn |
| Sep 30, 2023 | 325.45 Mn |
| Jun 30, 2023 | 220.64 Mn |
| Mar 31, 2023 | 219.43 Mn |
| Dec 31, 2022 | 237.96 Mn |
| Sep 30, 2022 | 184.51 Mn |
| Jun 30, 2022 | 142.27 Mn |
| Mar 31, 2022 | 156.53 Mn |
| Dec 31, 2021 | 198.57 Mn |
| Sep 30, 2021 | 141.06 Mn |
API Access
Alnylam Pharmaceuticals Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=ALNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "ALNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=ALNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();